2025. DEVELOPMENT AND OPTIMIZATION OF SOLID LIPID NANOPARTICLES OF DASATINIB USING DESIGN OF EXPERIMENTS: IN VITRO DRUGRELEASE AND IN-VIVO PHARMACOKINETIC STUDIES. INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIOMEDICAL ANALYSIS. 14, 2 (Apr. 2025), 85–105.